Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and Aortic Stenosis

tolvaptan has been researched along with Aortic Stenosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Fukumoto, Y; Shimozono, K1
Hayashida, K; Hioki, H; Izumo, M; Jujo, K; Kataoka, A; Kawashima, H; Kozuma, K; Mizutani, K; Nakashima, M; Nakazawa, G; Nara, Y; Nishihata, Y; Tanaka, J; Watanabe, Y; Yamamoto, M1
Daida, H; Hiki, M; Kasai, T; Kato, T; Miyauchi, K; Miyazaki, T; Murata, A; Negoro, K; Shimizu, M; Suda, S; Takasu, K; Yatsu, S1
Hioki, H; Kataoka, A; Kawashima, H; Kozuma, K; Mitsui, M; Nagura, F; Nakashima, M; Nara, Y; Watanabe, Y; Yokoyama, N1
Kajimoto, K; Otsubo, S1

Other Studies

5 other study(ies) available for tolvaptan and Aortic Stenosis

ArticleYear
Effectiveness and Safety of Tolvaptan in Patients with Aortic Stenosis.
    The Kurume medical journal, 2022, Mar-11, Volume: 67, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Aortic Valve Stenosis; Benzazepines; Heart Failure; Humans; Retrospective Studies; Tolvaptan

2022
Short-term effects of low-dose tolvaptan in acute decompensated heart failure patients with severe aortic stenosis: The LOHAS registry.
    International journal of cardiology, 2020, 04-15, Volume: 305

    Topics: Antidiuretic Hormone Receptor Antagonists; Aortic Valve Stenosis; Benzazepines; Heart Failure; Humans; Registries; Tolvaptan

2020
Successful Treatment of Congestive Heart Failure Due to Severe Aortic Valve Stenosis With Low Dose Tolvaptan in Elderly Patients.
    International heart journal, 2017, May-31, Volume: 58, Issue:3

    Topics: Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Aortic Valve Stenosis; Benzazepines; Dose-Response Relationship, Drug; Echocardiography; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Male; Retrospective Studies; Severity of Illness Index; Tolvaptan; Treatment Outcome; Urination

2017
Clinical safety and efficacy of tolvaptan for acute phase therapy in patients with low-flow and normal-flow severe aortic stenosis.
    Heart and vessels, 2019, Volume: 34, Issue:10

    Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Aortic Valve Stenosis; Female; Glomerular Filtration Rate; Heart Failure; Humans; Japan; Male; Retrospective Studies; Time Factors; Tolvaptan; Treatment Outcome; Urination

2019
Adding High-Dose Spironolactone to Tolvaptan Improves Acute Decompensated Heart Failure Due to Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis: A Case Report.
    The American journal of case reports, 2019, Jul-12, Volume: 20

    Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Aortic Valve Stenosis; Cardiomyopathy, Hypertrophic; Drug Therapy, Combination; Dyspnea; Female; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone; Tolvaptan

2019